Literature DB >> 20685224

Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.

Morteza Mahmoudi1, Shilpa Sant, Ben Wang, Sophie Laurent, Tapas Sen.   

Abstract

At present, nanoparticles are used for various biomedical applications where they facilitate laboratory diagnostics and therapeutics. More specifically for drug delivery purposes, the use of nanoparticles is attracting increasing attention due to their unique capabilities and their negligible side effects not only in cancer therapy but also in the treatment of other ailments. Among all types of nanoparticles, biocompatible superparamagnetic iron oxide nanoparticles (SPIONs) with proper surface architecture and conjugated targeting ligands/proteins have attracted a great deal of attention for drug delivery applications. This review covers recent advances in the development of SPIONs together with their possibilities and limitations from fabrication to application in drug delivery. In addition, the state-of-the-art synthetic routes and surface modification of desired SPIONs for drug delivery purposes are described.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685224     DOI: 10.1016/j.addr.2010.05.006

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  223 in total

Review 1.  Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer.

Authors:  Liangqian Tong; Ming Zhao; Shu Zhu; Jing Chen
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

Review 2.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.

Authors:  Morteza Mahmoudi; Mohammad A Sahraian; Mohammad A Shokrgozar; Sophie Laurent
Journal:  ACS Chem Neurosci       Date:  2011-02-04       Impact factor: 4.418

Review 3.  Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Authors:  Houshang Amiri; Kolsoum Saeidi; Parvin Borhani; Arash Manafirad; Mahdi Ghavami; Valerio Zerbi
Journal:  ACS Chem Neurosci       Date:  2013-09-26       Impact factor: 4.418

Review 4.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

5.  Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10-NGR9 ultrasmall superparamagnetic iron oxide nanoparticles.

Authors:  T Wu; X Ding; B Su; A K Soodeen-Lalloo; L Zhang; J-Y Shi
Journal:  Clin Transl Oncol       Date:  2017-09-27       Impact factor: 3.405

6.  Selection of a suitable method for the preparation of polymeric nanoparticles: multi-criteria decision making approach.

Authors:  Kannan Krishnamoorthy; Manikandan Mahalingam
Journal:  Adv Pharm Bull       Date:  2015-03-05

7.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

8.  SPIO-Au core-shell nanoparticles for promoting osteogenic differentiation of MC3T3-E1 cells: Concentration-dependence study.

Authors:  Muzhaozi Yuan; Ya Wang; Yi-Xian Qin
Journal:  J Biomed Mater Res A       Date:  2017-09-19       Impact factor: 4.396

9.  Impact of Serum Proteins on MRI Contrast Agents: Cellular Binding and T2 relaxation.

Authors:  Alexandra Hill; Christine K Payne
Journal:  RSC Adv       Date:  2014       Impact factor: 3.361

10.  Response difference of transgenic and conventional rice (Oryza sativa) to nanoparticles (γFe₂O₃).

Authors:  Xin Gui; Yingqing Deng; Yukui Rui; Binbin Gao; Wenhe Luo; Shili Chen; Le Van Nhan; Xuguang Li; Shutong Liu; Yaning Han; Liming Liu; Baoshan Xing
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-09       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.